Laboratory Diagnosis of Vaginal Candidiasis: Species Identification, Diagnostic Accuracy, and Clinical Utility
Current Fungal Infection Reports · 2026-12 · 20 (1)
DOI: 10.1007/s12281-026-00546-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Fungal Infection Reports, online erschienen am 06.11.2026. Verfasst von Sumita Bhatia und 5 weiteren Autor:innen. Die Arbeit nennt 104 Literaturangaben.
Abstract (Originalsprache)
Purpose of Review Vulvovaginal candidiasis (VVC) is a frequent contributor to vulvovaginal symptoms; however, its clinical features are similar to those of bacterial vaginosis, trichomoniasis, mixed vaginitis, and non-infectious vulvovaginal disorders. Current laboratory approaches for vulvovaginal candidiasis are examined in terms of diagnostic accuracy, species determination, antifungal susceptibility testing, and clinical use. Evidence was synthesized from microscopy, potassium hydroxide preparation, culture techniques, species-distribution studies, molecular diagnostic assays, multiplex panels for vaginitis, susceptibility studies, and implementation research. Recent Findings Microscopy offers rapid and inexpensive evaluation but has limited sensitivity, particularly in low-burden infections and diseases caused by non-albicans Candida species. Culture still plays an important role in organism recovery, species identification, detection of mixed infections, and determination of antifungal susceptibility; however, its interpretation is limited by delayed turnaround time, sampling conditions, previous antifungal exposure, and the inability to distinguish colonization from infection. In non-albicans disease and recurrent, persistent, or refractory infections, antifungal susceptibility testing is most helpful. Summary Species-level identification is becoming increasingly relevant, given the differences in epidemiology, recurrence, and antifungal response among Candida species. Molecular assays provide higher sensitivity, more rapid turnaround, and detection of co-infections. However, highly sensitive assays can lead to the detection of asymptomatic colonization and potential overtreatment when laboratory findings are not correlated with clinical presentation. A tiered laboratory workflow combining symptom assessment, microscopy, culture, species identification, selective molecular testing, and targeted susceptibility testing is the most clinically informative and provides complementary information to support patient management.
Zitieren
APA
Bhatia, S., Prabhakaran, G., Subramani, P., Kumar, N., Narain, K., & Fuloria, N. K. (2026). Laboratory Diagnosis of Vaginal Candidiasis: Species Identification, Diagnostic Accuracy, and Clinical Utility. Current Fungal Infection Reports, 20(1). https://doi.org/10.1007/s12281-026-00546-x
Vancouver
Bhatia S, Prabhakaran G, Subramani P, Kumar N, Narain K, Fuloria NK. Laboratory Diagnosis of Vaginal Candidiasis: Species Identification, Diagnostic Accuracy, and Clinical Utility. Current Fungal Infection Reports. 2026;20(1). doi:10.1007/s12281-026-00546-x
BibTeX
@article{Bhatia2026,
author = {Bhatia, Sumita and Prabhakaran, Guruswamy and Subramani, Parasuraman and Kumar, Neeraj and Narain, Kamal and Fuloria, Neeraj Kumar},
title = {Laboratory Diagnosis of Vaginal Candidiasis: Species Identification, Diagnostic Accuracy, and Clinical Utility},
journal = {Current Fungal Infection Reports},
year = {2026},
volume = {20},
number = {1},
doi = {10.1007/s12281-026-00546-x}
}
EUVIMED